SCHEMBL25474698

SCHEMBL25474698

CC(C)CCCCNC(=O)Nc1ccc(CC(C)C)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 5/20 0.53
SLC6A3 Q01959 2/20 0.50
MAPT P10636 2/20 0.49
LMNA P02545 1/20 0.49
TRPV1 Q8NER1 4/20 0.48
ALDH1A1 P00352 2/20 0.48
HTT P42858 1/20 0.48
FOLH1 Q04609 5/20 0.47
GAA P10253 1/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
HDAC3 O15379 1/20 0.46
HDAC4 P56524 1/20 0.46
HDAC1 Q13547 1/20 0.46
HDAC7 Q8WUI4 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25474694 0.83 TRPV1 (0.43) EPHX1MAPTLMNATRPV1ALDH1A1
SCHEMBL25474697 0.83 LMNA (0.57) MAPTLMNAALDH1A1HTTGAA
SCHEMBL21501999 0.80 MAPT (0.52) EPHX1MAPTLMNAFOLH1GAA
SCHEMBL25473525 0.79 HDAC3 (0.57) MAPTTRPV1GAACRHBPCRHR2
SCHEMBL25473507 0.78 HDAC3 (0.56) TRPV1HDAC3HDAC4HDAC1HDAC7
SCHEMBL25064819 0.78 HDAC3 (0.56) TRPV1HDAC3HDAC4HDAC1HDAC7
SCHEMBL10160141 0.77 SMN1; SMN2 (0.55) EPHX1MAPTLMNAALDH1A1FOLH1
SCHEMBL23634207 0.75 CA12 (0.55) MAPTLMNAFOLH1GAACRHBP
SCHEMBL20715474 0.75 SMN1; SMN2 (0.59) EPHX1MAPTLMNATRPV1GAA
SCHEMBL21754555 0.75 TRPV1 (0.49) MAPTTRPV1GAACRHBPCRHR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230149569-A1 MULTIFUNCTIONAL COMPOUNDS FOR USE IN MEDICAL IMAGING AND THERAPY ANTELOPE SURGICAL SOLUTIONS, INC. 2023-05-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230149569-A1 MULTIFUNCTIONAL COMPOUNDS FOR USE IN MEDICAL IMAGING AND THERAPY PAICS, BID, OGFR EPHX1 3441/4885SLC6A3 1999/4885MAPT 466/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.